Detalhe da pesquisa
1.
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Blood
; 140(5): 491-503, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476848
2.
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.
Am J Hematol
; 98(12): E360-E363, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705256
3.
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Cancer
; 128(21): 3880-3887, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107670
4.
Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Int J Mol Sci
; 23(19)2022 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232559
5.
Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes.
Eur J Haematol
; 107(6): 609-616, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407254
6.
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia.
Am J Hematol
; 96(4): 462-470, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502020
7.
Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology.
Cancer Control
; 22(2): 158-66, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26068760
8.
Haemophagocytic lymphohistiocytosis has variable time to onset following CD19 chimeric antigen receptor T cell therapy.
Br J Haematol
; 187(2): e35-e38, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410842
9.
Clonotypic VDJ rearrangements in Mixed Phenotype Acute Leukemia can be Successfully Utilized to Track Minimal Residual Disease (MRD).
Appl Immunohistochem Mol Morphol
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695552
10.
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.
Blood Adv
; 8(5): 1075-1083, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170740
11.
Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein-Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma.
Case Rep Hematol
; 2023: 8833273, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028985
12.
Sclerotic marginal zone lymphoma: A case report.
World J Methodol
; 13(4): 366-372, 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771876
13.
Co-mutation of ASXL1 and SF3B1 Predicts Poorer Overall Survival Than Isolated ASXL1 or SF3B1 Mutations.
In Vivo
; 37(3): 985-993, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103105
14.
Designing Tailored Thiosemicarbazones with Bespoke Properties: The Styrene Moiety Imparts Potent Activity, Inhibits Heme Center Oxidation, and Results in a Novel "Stealth Zinc(II) Complex".
J Med Chem
; 66(2): 1426-1453, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649565
15.
Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients.
Leuk Res
; 124: 106999, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542963
16.
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
Int J Lab Hematol
; 45(5): 726-734, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282364
17.
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
Clin Lymphoma Myeloma Leuk
; 23(5): 355-359, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813626
18.
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Hum Pathol
; 136: 1-15, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958463
19.
An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases.
Arch Pathol Lab Med
; 147(7): 837-846, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170615
20.
Expanding diagnostic criteria: Multiorgan T-Cell/myeloid mixed phenotype acute leukemia with t(v;11q23) KMT2A-rearrangement successfully treated by allogeneic stem cell transplant.
Leuk Res Rep
; 17: 100306, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35356416